European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 5 , Pages 491-493, November 2006

Secondary Prevention of Arteriosclerosis in Lower Limb Vascular Amputees: A Missed Opportunity

  • L. Bradley
  • ,
  • S.G.B. Kirker

      Affiliations

    • Corresponding Author InformationCorresponding author. Dr. S.G.B. Kirker, MD, FRCPI, Addenbrooke's Hospital, Disablement Services Centre, Cambridge CB2 2QQ, UK.

Disablement Services Centre, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK

Accepted 13 July 2006. published online 25 August 2006.

Objectives

To determine the numbers of patients with peripheral vascular disease prescribed secondary prevention agents following a lower limb amputation.

Design

A retrospective cross sectional study.

Methods

The clinical documentation of 107 vascular amputees (mean age 69.5, 2:1 male:female ratio) referred for prosthesis provision in 2004 and 2005 were analysed to determine levels of prescribing of anti-platelet agents, anti-coagulants and cholesterol lowering drugs.

Results

Analysis of vascular amputees referred in 2004 and 2005 reveals that 41% were prescribed a statin and 39% were prescribed a statin and 60% an anti-platelet agent. While 39% of these patients were on both drugs, 32% had been prescribed neither.

Conclusions

The medical management of patients with severe peripheral vascular disease, even where their disease has led to an amputation, is sub-optimal.

Keywords: Amputation, Secondary prevention, Peripheral vascular disease, Statin

 

PII: S1078-5884(06)00387-X

doi:10.1016/j.ejvs.2006.07.005

European Journal of Vascular & Endovascular Surgery
Volume 32, Issue 5 , Pages 491-493, November 2006